• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec31
Farasis Medical Acquires Hebei Yunda Jiufu Biotechnology Co., Ltd. to Strengthen Amino Acid Industrial Chain Layout
08:56
Dec30
Yuanda Pharmaceutical Makes Breakthroughs in Nuclear Medicine Oncology
01:05
Dec29
Farapulse Secures Commercialization Rights for Neffy® in Mainland China
09:07
Dec23
Farmito Obtains Exclusive Commercialization Rights for Neffy® in Mainland China
09:10
Dec21
Yongan Pharmaceutical's TLX591-CDx Phase III Clinical Trial Reaches Primary Endpoint
10:14
Dec19
19:14

Schedules & Filings

Schedules
Filings
Aug19
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 3.054 B, Net Income 584.51 M, EPS 0.1669

Apr28
Distribution Plan(CST)

Cash dividend 0.26 HKD

Apr15
Distribution Plan(CST)

Cash dividend 0.26 HKD

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
02422
1.150
+64.29%
+0.450
08146
0.385
+45.28%
+0.120
02405
1.300
+35.42%
+0.340
08333
0.460
+27.78%
+0.100
01147
0.145
+27.19%
+0.031
06928
0.275
+26.73%
+0.058
03696
37.140
+23.88%
+7.160
08635
0.730
+23.73%
+0.140
02515
0.920
+22.67%
+0.170
09958
0.155
+22.05%
+0.028
View More